Standard Biotools (LAB) Other Non-Current Assets (2010 - 2026)
Standard Biotools (LAB) posted quarterly Other Non-Current Assets of $3.4 million for Q1 2026, down 47.96% year-over-year from $6.5 million in Q1 2025, and down 98.52% quarter-over-quarter from $228.4 million in Q4 2025.
Standard Biotools (LAB) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Standard Biotools (LAB) has reported Other Non-Current Assets for 17 consecutive years, with $3.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Assets fell 47.96% year-over-year to $3.4 million; the TTM figure through Mar 2026 stood at $3.4 million (down 47.96% YoY), while the FY2025 annual figure was $228.4 million, up 24.52% from the prior year.
- Other Non-Current Assets declined to $3.4 million in Q1 2026 per LAB's latest filing, from $228.4 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $228.4 million in Q4 2025 and bottomed at $2.3 million in Q4 2023.
- Historically, Other Non-Current Assets has averaged $30.5 million across 5 years, with a median of $3.4 million in 2026.
- Annual changes were most pronounced in 2024 — Other Non-Current Assets jumped 7927.66% — and 2026, when it sank 47.96%.
- Standard Biotools' Other Non-Current Assets stood at $3.1 million in 2022, then decreased by 26.5% to $2.3 million in 2023, then surged by 7927.66% to $183.4 million in 2024, then gained by 24.52% to $228.4 million in 2025, then slumped by 98.52% to $3.4 million in 2026.
- Business Quant data shows LAB's Other Non-Current Assets at $3.4 million in Q1 2026, $228.4 million in Q4 2025, and $6.5 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.23 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 616.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 273.70 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 148.78 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Standard Biotools | 250.59 Mn | -226.13 Mn | 10.54 Mn | 3.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.26 Mn |
| Mar 31, 2026 | 3.39 Mn |
| Dec 31, 2025 | 228.41 Mn |
| Mar 31, 2025 | 6.51 Mn |
| Dec 31, 2024 | 183.43 Mn |
| Sep 30, 2024 | 4.64 Mn |
| Jun 30, 2024 | 4.28 Mn |
| Mar 31, 2024 | 3.67 Mn |
| Dec 31, 2023 | 2.29 Mn |
| Sep 30, 2023 | 2.39 Mn |
| Jun 30, 2023 | 2.75 Mn |
| Mar 31, 2023 | 2.67 Mn |
| Dec 31, 2022 | 3.11 Mn |
| Sep 30, 2022 | 3.12 Mn |
| Jun 30, 2022 | 3.16 Mn |
| Mar 31, 2022 | 3.45 Mn |
| Dec 31, 2021 | 3.69 Mn |
| Sep 30, 2021 | 4.69 Mn |
| Jun 30, 2021 | 4.11 Mn |
| Mar 31, 2021 | 4.39 Mn |